Geneva Advisors’s GLYCOGENESYS INC. NEW GLGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-11,030
Closed 758
2014
Q4
$0 Hold
11,030
﹤0.01% 772
2014
Q3
$0 Hold
11,030
﹤0.01% 757
2014
Q2
$0 Hold
11,030
﹤0.01% 760
2014
Q1
$0 Hold
11,030
﹤0.01% 724
2013
Q4
$0 Hold
11,030
﹤0.01% 617
2013
Q3
$0 Buy
+11,030
New ﹤0.01% 576

Geneva Advisors's GLGS Position: Q1 2015 in Review

Geneva Advisors sold out of GLYCOGENESYS INC. NEW (GLGS) in Q1 2015, closing a stake of 11,030 shares.

Geneva Advisors first reported a position in GLGS in Q3 2013 and held it in 6 quarters. The position peaked at $0 in Q4 2014. 0 funds tracked by Wall St. Rank hold GLGS as of Q1 2015.

  • Geneva Advisors reported no remaining GLYCOGENESYS INC. NEW position as of Q1 2015 after selling out during the quarter.
  • Geneva Advisors sold 11,030 GLYCOGENESYS INC. NEW shares in Q1 2015.
  • Geneva Advisors first reported a position in GLYCOGENESYS INC. NEW in Q3 2013 and held it in 6 quarters.
  • Geneva Advisors's GLYCOGENESYS INC. NEW position peaked at $0 in Q4 2014.
  • 0 funds tracked by Wall St. Rank held GLYCOGENESYS INC. NEW as of Q1 2015.

Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.